– MARIO-4, the first eganelisib registration-enabling trial, in front-line metastatic triple negative breast cancer expected to initiate by the end of 2022 – – MARIO-P, a study designed to expand ...
SANTA ANA, CA / / February 5, 2026 / Infinity Bancorp (OTCQB:INFT) (the "Company" or "Bancorp"), the holding company for ...
SANTA ANA, CA / ACCESS Newswire / February 6, 2026 / Infinity Bancorp (OTCQB:INFT) (the "Company" or "Bancorp"), the holding ...
SAN DIEGO, CA. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--MEI Pharma, Inc. (Nasdaq: MEIP) (“MEI”), a clinical-stage pharmaceutical company focused on advancing new ...
Infinity Trust Mortgage Bank Plc engages in providing mortgage banking, construction finance, and other financial services to corporate and individual customers. Its products include mortgage finance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results